Sales Support
U.S.:+1-415-871-0703
U.K.:+44-203-289-4040
JAPAN: +81-50-5539-1737
INDIA:+91-848-285-0837
Contact Us
We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.
Healthcare and Pharmaceuticals industry

Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2025

  • Purchase Options

 
In this report, the Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing market is valued at USD XX million in 2019 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2019 and 2025.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Viral Vectors and Plasmid DNA Manufacturing for these regions, from 2018 to 2025 (forecast), including
China
Japan
South Korea
Taiwan
India
Southeast Asia
Australia

Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing market competition by top manufacturers/players, with Viral Vectors and Plasmid DNA Manufacturing sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Aldevron
Eurogentec
Richter-Helm
BioReliance
Biovian
Brammer Bio
Cell and Gene Therapy Catapult
Cobra Biologics
FinVector
FUJIFILM Diosynth Biotechnologies
Lonza
MassBiologics
MolMed
Oxford BioMedica
Sanofi (CEPiA, Sanofi Pasteur, Genzyme)
Spark Therapeutics
UniQure
ViGene Biosciences
Wuxi AppTec

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
Plasmid DNA
Viral Vectors
Non-Viral Vectors

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Viral Vectors and Plasmid DNA Manufacturing for each application, includin
Cancers
Inherited Disorders
Viral Infections
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Report 2019
1 Viral Vectors and Plasmid DNA Manufacturing Overview
1.1 Product Overview and Scope of Viral Vectors and Plasmid DNA Manufacturing
1.2 Classification of Viral Vectors and Plasmid DNA Manufacturing by Product Category
1.2.1 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size (Sales) Comparison by Types (2014-2024)
1.2.2 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Plasmid DNA
1.2.4 Viral Vectors
1.2.5 Non-Viral Vectors
1.3 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market by Application/End Users
1.3.1 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Sales (Volume) and Market Share Comparison by Applications (2014-2024)
1.3.2 Cancers
1.3.3 Inherited Disorders
1.3.4 Viral Infections
1.3.5 Others
1.4 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market by Region
1.4.1 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size (Value) Comparison by Region (2014-2024)
1.4.2 China Status and Prospect (2014-2024)
1.4.3 Japan Status and Prospect (2014-2024)
1.4.4 South Korea Status and Prospect (2014-2024)
1.4.5 Taiwan Status and Prospect (2014-2024)
1.4.6 India Status and Prospect (2014-2024)
1.4.7 Southeast Asia Status and Prospect (2014-2024)
1.4.8 Australia Status and Prospect (2014-2024)
1.5 Asia-Pacific Market Size (Value and Volume) of Viral Vectors and Plasmid DNA Manufacturing (2014-2024)
1.5.1 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate (2014-2024)
1.5.2 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2024)

2 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Competition by Players/Suppliers, Region, Type and Application
2.1 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Competition by Players/Suppliers
2.1.1 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Sales Volume and Market Share of Key Players/Suppliers (2014-2019)
2.1.2 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue and Share by Players/Suppliers (2014-2019)
2.2 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing (Volume and Value) by Type
2.2.1 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Type (2014-2019)
2.2.2 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue and Market Share by Type (2014-2019)
2.3 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing (Volume) by Application
2.4 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing (Volume and Value) by Region
2.4.1 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Region (2014-2019)
2.4.2 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue and Market Share by Region (2014-2019)

3 China Viral Vectors and Plasmid DNA Manufacturing (Volume, Value and Sales Price)
3.1 China Viral Vectors and Plasmid DNA Manufacturing Sales and Value (2014-2019)
3.1.1 China Viral Vectors and Plasmid DNA Manufacturing Sales Volume and Growth Rate (2014-2019)
3.1.2 China Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2019)
3.1.3 China Viral Vectors and Plasmid DNA Manufacturing Sales Price Trend (2014-2019)
3.2 China Viral Vectors and Plasmid DNA Manufacturing Sales Volume and Market Share by Type
3.3 China Viral Vectors and Plasmid DNA Manufacturing Sales Volume and Market Share by Application

4 Japan Viral Vectors and Plasmid DNA Manufacturing (Volume, Value and Sales Price)
4.1 Japan Viral Vectors and Plasmid DNA Manufacturing Sales and Value (2014-2019)
4.1.1 Japan Viral Vectors and Plasmid DNA Manufacturing Sales Volume and Growth Rate (2014-2019)
4.1.2 Japan Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2019)
4.1.3 Japan Viral Vectors and Plasmid DNA Manufacturing Sales Price Trend (2014-2019)
4.2 Japan Viral Vectors and Plasmid DNA Manufacturing Sales Volume and Market Share by Type
4.3 Japan Viral Vectors and Plasmid DNA Manufacturing Sales Volume and Market Share by Application

5 South Korea Viral Vectors and Plasmid DNA Manufacturing (Volume, Value and Sales Price)
5.1 South Korea Viral Vectors and Plasmid DNA Manufacturing Sales and Value (2014-2019)
5.1.1 South Korea Viral Vectors and Plasmid DNA Manufacturing Sales Volume and Growth Rate (2014-2019)
5.1.2 South Korea Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2019)
5.1.3 South Korea Viral Vectors and Plasmid DNA Manufacturing Sales Price Trend (2014-2019)
5.2 South Korea Viral Vectors and Plasmid DNA Manufacturing Sales Volume and Market Share by Type
5.3 South Korea Viral Vectors and Plasmid DNA Manufacturing Sales Volume and Market Share by Application

6 Taiwan Viral Vectors and Plasmid DNA Manufacturing (Volume, Value and Sales Price)
6.1 Taiwan Viral Vectors and Plasmid DNA Manufacturing Sales and Value (2014-2019)
6.1.1 Taiwan Viral Vectors and Plasmid DNA Manufacturing Sales Volume and Growth Rate (2014-2019)
6.1.2 Taiwan Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2019)
6.1.3 Taiwan Viral Vectors and Plasmid DNA Manufacturing Sales Price Trend (2014-2019)
6.2 Taiwan Viral Vectors and Plasmid DNA Manufacturing Sales Volume and Market Share by Type
6.3 Taiwan Viral Vectors and Plasmid DNA Manufacturing Sales Volume and Market Share by Application

7 India Viral Vectors and Plasmid DNA Manufacturing (Volume, Value and Sales Price)
7.1 India Viral Vectors and Plasmid DNA Manufacturing Sales and Value (2014-2019)
7.1.1 India Viral Vectors and Plasmid DNA Manufacturing Sales Volume and Growth Rate (2014-2019)
7.1.2 India Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2019)
7.1.3 India Viral Vectors and Plasmid DNA Manufacturing Sales Price Trend (2014-2019)
7.2 India Viral Vectors and Plasmid DNA Manufacturing Sales Volume and Market Share by Type
7.3 India Viral Vectors and Plasmid DNA Manufacturing Sales Volume and Market Share by Application

8 Southeast Asia Viral Vectors and Plasmid DNA Manufacturing (Volume, Value and Sales Price)
8.1 Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Sales and Value (2014-2019)
8.1.1 Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Sales Volume and Growth Rate (2014-2019)
8.1.2 Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2019)
8.1.3 Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Sales Price Trend (2014-2019)
8.2 Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Sales Volume and Market Share by Type
8.3 Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Sales Volume and Market Share by Application

9 Australia Viral Vectors and Plasmid DNA Manufacturing (Volume, Value and Sales Price)
9.1 Australia Viral Vectors and Plasmid DNA Manufacturing Sales and Value (2014-2019)
9.1.1 Australia Viral Vectors and Plasmid DNA Manufacturing Sales Volume and Growth Rate (2014-2019)
9.1.2 Australia Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2019)
9.1.3 Australia Viral Vectors and Plasmid DNA Manufacturing Sales Price Trend (2014-2019)
9.2 Australia Viral Vectors and Plasmid DNA Manufacturing Sales Volume and Market Share by Type
9.3 Australia Viral Vectors and Plasmid DNA Manufacturing Sales Volume and Market Share by Application

10 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Players/Suppliers Profiles and Sales Data
10.1 Aldevron
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Viral Vectors and Plasmid DNA Manufacturing Product Category, Application and Specification
10.1.2.1 Product A
10.1.2.2 Product B
10.1.3 Aldevron Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2014-2019)
10.1.4 Main Business/Business Overview
10.2 Eurogentec
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Viral Vectors and Plasmid DNA Manufacturing Product Category, Application and Specification
10.2.2.1 Product A
10.2.2.2 Product B
10.2.3 Eurogentec Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2014-2019)
10.2.4 Main Business/Business Overview
10.3 Richter-Helm
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Viral Vectors and Plasmid DNA Manufacturing Product Category, Application and Specification
10.3.2.1 Product A
10.3.2.2 Product B
10.3.3 Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2014-2019)
10.3.4 Main Business/Business Overview
10.4 BioReliance
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Viral Vectors and Plasmid DNA Manufacturing Product Category, Application and Specification
10.4.2.1 Product A
10.4.2.2 Product B
10.4.3 BioReliance Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2014-2019)
10.4.4 Main Business/Business Overview
10.5 Biovian
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Viral Vectors and Plasmid DNA Manufacturing Product Category, Application and Specification
10.5.2.1 Product A
10.5.2.2 Product B
10.5.3 Biovian Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2014-2019)
10.5.4 Main Business/Business Overview
10.6 Brammer Bio
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Viral Vectors and Plasmid DNA Manufacturing Product Category, Application and Specification
10.6.2.1 Product A
10.6.2.2 Product B
10.6.3 Brammer Bio Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2014-2019)
10.6.4 Main Business/Business Overview
10.7 Cell and Gene Therapy Catapult
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Viral Vectors and Plasmid DNA Manufacturing Product Category, Application and Specification
10.7.2.1 Product A
10.7.2.2 Product B
10.7.3 Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2014-2019)
10.7.4 Main Business/Business Overview
10.8 Cobra Biologics
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Viral Vectors and Plasmid DNA Manufacturing Product Category, Application and Specification
10.8.2.1 Product A
10.8.2.2 Product B
10.8.3 Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2014-2019)
10.8.4 Main Business/Business Overview
10.9 FinVector
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Viral Vectors and Plasmid DNA Manufacturing Product Category, Application and Specification
10.9.2.1 Product A
10.9.2.2 Product B
10.9.3 FinVector Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2014-2019)
10.9.4 Main Business/Business Overview
10.10 FUJIFILM Diosynth Biotechnologies
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Viral Vectors and Plasmid DNA Manufacturing Product Category, Application and Specification
10.10.2.1 Product A
10.10.2.2 Product B
10.10.3 FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2014-2019)
10.10.4 Main Business/Business Overview
10.11 Lonza
10.12 MassBiologics
10.13 MolMed
10.14 Oxford BioMedica
10.15 Sanofi (CEPiA, Sanofi Pasteur, Genzyme)
10.16 Spark Therapeutics
10.17 UniQure
10.18 ViGene Biosciences
10.19 Wuxi AppTec

11 Viral Vectors and Plasmid DNA Manufacturing Manufacturing Cost Analysis
11.1 Viral Vectors and Plasmid DNA Manufacturing Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Viral Vectors and Plasmid DNA Manufacturing

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Viral Vectors and Plasmid DNA Manufacturing Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Viral Vectors and Plasmid DNA Manufacturing Major Manufacturers in 2016
12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List

14 Market Effect Factors Analysis
14.1 Technology Progress/Risk
14.1.1 Substitutes Threat
14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Forecast (2019-2024)
15.1 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Sales Volume, Revenue and Price Forecast (2019-2024)
15.1.1 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Sales Volume and Growth Rate Forecast (2019-2024)
15.1.2 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate Forecast (2019-2024)
15.1.3 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Price and Trend Forecast (2019-2024)
15.2 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Sales Volume, Revenue and Growth Rate Forecast by Region (2019-2024)
15.2.1 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Sales Volume and Growth Rate Forecast by Region (2019-2024)
15.2.2 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate Forecast by Region (2019-2024)
15.2.3 China Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue and Growth Rate Forecast (2019-2024)
15.2.4 Japan Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue and Growth Rate Forecast (2019-2024)
15.2.5 South Korea Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue and Growth Rate Forecast (2019-2024)
15.2.6 Taiwan Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue and Growth Rate Forecast (2019-2024)
15.2.7 India Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue and Growth Rate Forecast (2019-2024)
15.2.8 Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue and Growth Rate Forecast (2019-2024)
15.2.9 Australia Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue and Growth Rate Forecast (2019-2024)
15.3 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue and Price Forecast by Type (2019-2024)
15.3.1 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Sales Forecast by Type (2019-2024)
15.3.2 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue Forecast by Type (2019-2024)
15.3.3 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Price Forecast by Type (2019-2024)
15.4 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Sales Forecast by Application (2019-2024)

16 Research Findings and Conclusion

17 Appendix
17.1 Methodology/Research Approach
17.1.1 Research Programs/Design
17.1.2 Market Size Estimation
17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
17.2.1 Secondary Sources
17.2.2 Primary Sources
17.3 Disclaimer


 

  • Purchase Options

  • Happy To Assist You

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.

Contact us